Definitions

  1. Law
  2. Georgia Code
  3. Health
  4. Terminally Ill Patient's Right to Try Investigational Drugs, Biological Products, and Devices
  5. Definitions

Checkout our iOS App for a better way to browser and research.

As used in this chapter, the term:

  1. "Eligible patient" means a person who meets the requirements of Code Section 31-52-4.
  2. "Investigational drug, biological product, or device" means a drug, biological product, or device which has successfully completed Phase I of a federal Food and Drug Administration approved clinical trial but has not yet been approved for general use by the federal Food and Drug Administration and currently remains under investigation in a federal Food and Drug Administration approved clinical trial.
  3. "Physician" means a person licensed to practice medicine pursuant to Article 2 of Chapter 34 of Title 43.
  4. "Terminal illness" means a disease that, without life-sustaining procedures, will result in death in the near future and is not considered by a treating physician to be reversible even with administration of current federal Food and Drug Administration approved and available treatments.
  5. "Written informed consent" means a written document that:
    1. Is signed by the patient; parent, if the patient is a minor; legal guardian; or health care agent designated by the patient in an advance directive for health care executed pursuant to Chapter 32 of Title 31;
    2. Is attested to by the patient's physician and a witness; and
    3. Meets the requirements of Code Section 31-52-5.

(Code 1981, §31-52-3, enacted by Ga. L. 2016, p. 345, § 1/HB 34.)


Download our app to see the most-to-date content.